Richard Mulligan Bausch Health Companies Inc. (BHC) insider trading activity

Richard Mulligan is Director of Bausch Health Companies Inc.. Currently has a direct ownership of 155,616 shares of BHC, which is worth approximately $756,293. The most recent transaction as insider was on May 16, 2025, when has been sold 54,347 shares (Common Shares, no par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 156K

136.11% 3M change

136.11% 12M change

Total Value Held $756,293

Richard Mulligan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2025	BUY Grant, award, or other acquisition	-	54,347 Added 25.88%	155,616 Common Shares, no par ...
May 19 2023	BUY Grant, award, or other acquisition	-	29,205 Added 30.71%	65,909 Common Shares, no par ...
Jun 24 2022	BUY Grant, award, or other acquisition	-	34,387 Added 48.37%	36,704 Common Shares, no par ...
May 13 2022	BUY Grant, award, or other acquisition	-	2,317 Added 50.0%	2,317 Common Shares, no par ...

Also insider at

BIIB

BIOGEN INC. Healthcare

Director

SANA

Sana Biotechnology, Inc. Healthcare